LJUBLJANA, Nov 14 (Reuters) - Generic drugs maker Krka KRKG.LJ KRK.WA , Slovenia's largest listed company, posted a nine-month group net profit of 124.9 million euros ($1.67 billion), up 12 percent on the same period in 2012. Krka said in a statement on Thursday sales had risen by 5 percent to 857.8 million euros and were expected to reach 1.25 billion euros next year compared to the 1.2 billion expected in 2013. The company expects 2013 net profit to be slightly above 159.8 million euros reached in 2012. ($1 = 0.7460 euros) (Reporting By Marja Novak; editing by Zoran Radosavljevic and Elaine Hardcastle) ((Marja.Novak@thomsonreuters.com)(+386-1-4700520)(Reuters Messaging: marja.novak.thomsonreuters.com@reuters.net)) Keywords: SLOVENIA KRKA/